搜尋結果
Canada’s China EV Tariff Plan Draws Debate Over Best Approach
Bloomberg· 1 小時前Automotive and environmental groups are at odds over how far Canada should go in imposing new ...
Argenx’s Vyvgart Shot Gains US Approval for Rare Nerve Disorder
Bloomberg· 1 小時前Argenx SE’s Vyvgart Hytrulo shot gained US approval to treat a rare nervous system disorder, a ...
The fight over Fisker's assets is already heating up
TechCrunch· 2 小時前At issue is the relationship between Fisker and its largest secured lender, Heights Capital ...
Arrests at Euro 2024 in Berlin after trouble involving "mostly Polish" fans
Reuters· 2 小時前Berlin police said on Friday they had made arrests after an altercation involving "mostly ...
Appeals court does not block US mandate to cover cancer screenings, HIV drugs
Reuters· 2 小時前A U.S. appeals court on Friday refused to block a federal mandate requiring health insurers to ...
Weight-loss drug Zepbound resolves sleep apnea in up to 52% of patients, Lilly says
Reuters· 2 小時前, opens new tab on Friday said its popular weight-loss drug Zepbound helped resolve moderate to ...
Eli Lilly expects FDA decision on weight loss drug Zepbound for sleep apnea as early as end of ...
CNBC· 3 小時前If cleared by the Food and Drug Administration, the company plans to launch Zepbound for ...
Wall St Week Ahead Rally in U.S. big tech stocks may be getting stretched
Reuters· 3 小時前A blistering rally in U.S. big tech stocks may be due for a breather, offering hope for market ...
Securities are in the eye of the beholder
TechCrunch· 3 小時前The publicly traded exchange has been under investigation for allegedly selling crypto tokens ...
Tesla has downsized by at least 14% this year after Elon Musk said layoffs would exceed 10%
CNBC· 3 小時前Tesla CEO Elon Musk sent an email to "everybody" that day. Tesla's plan to ...